Wikidata

(Q33387077)

English

Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study

scientific article

In more languages

Statements

title
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19921192
retrieved
26 July 2017
author name string
Yeo-Kyeoung Kim
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19921192
retrieved
26 July 2017
Sang-Kyun Sohn
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19921192
retrieved
26 July 2017
Jae-Hoon Lee
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19921192
retrieved
26 July 2017
Deok-Hwan Yang
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19921192
retrieved
26 July 2017
Joon-Ho Moon
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
19921192
retrieved
26 July 2017
Jae-Sook Ahn
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
19921192
retrieved
26 July 2017
Hyeoung-Joon Kim
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
19921192
retrieved
26 July 2017
Korean Multiple Myeloma Working Party (KMMWP)
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
19921192
retrieved
26 July 2017
publication date
18 November 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19921192
retrieved
26 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33387077&oldid=1711137179"